We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
(-0.66%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$588M |
| 2 |
CRH
CRH
|
+$47.1M |
| 3 |
Carvana
CVNA
|
+$34.4M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$33.9M |
| 5 |
Pinterest
PINS
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$326M |
| 2 |
Apple
AAPL
|
+$286M |
| 3 |
Microsoft
MSFT
|
+$251M |
| 4 |
MRSH
Marsh
MRSH
|
+$174M |
| 5 |
Amazon
AMZN
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Financials | 13.22% |
| 3 | Consumer Discretionary | 10.75% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Fennec Pharmaceuticals
FENC
$423M
| $224K | ﹤0.01% |
29,038
-4,484
| -13% | -$36.8K |
|
2877
Lands' End
LE
$390M
| $222K | ﹤0.01% |
15,296
-4,152
| -21% | -$64.1K |
|
2878
Pearson
PSO
$9.78B
| $221K | ﹤0.01% |
15,713
+3,640
| +30% | +$50.3K |
|
|
FUJI
2879
DELISTED
FUJI FILM HOLDINGS ADR 2 ORD
FUJI
| $220K | ﹤0.01% |
20,860
| – | – |
|
|
LPRO
2880
DELISTED
Open Lending Corp
LPRO
| $220K | ﹤0.01% |
142,194
-14,279
| -9% | -$25.3K |
|
2881
Cardiff Oncology
CRDF
$76.6M
| $220K | ﹤0.01% |
78,389
-8,867
| -10% | -$20.6K |
|
2882
Kingstone Companies
KINS
$282M
| $220K | ﹤0.01% |
13,088
-2,770
| -17% | -$42.1K |
|
|
NPB
2883
Northpointe Bancshares
NPB
$603M
| $220K | ﹤0.01% |
13,109
+3,100
| +31% | +$52.5K |
|
2884
Inogen
INGN
$154M
| $220K | ﹤0.01% |
32,713
-4,280
| -12% | -$32.1K |
|
2885
Blue Ridge Bankshares
BRBS
$336M
| $219K | ﹤0.01% |
51,405
-10,808
| -17% | -$46.9K |
|
2886
OraSure Technologies
OSUR
$277M
| $219K | ﹤0.01% |
90,694
-19,565
| -18% | -$51.5K |
|
2887
Qfin Holdings
QFIN
$1.52B
| $219K | ﹤0.01% |
11,352
-222
| -2% | -$4.99K |
|
2888
Foster
FSTR
$404M
| $218K | ﹤0.01% |
8,085
-1,036
| -11% | -$28K |
|
2889
Foghorn Therapeutics
FHTX
$385M
| $217K | ﹤0.01% |
40,117
-3,606
| -8% | -$16.3K |
|
2890
Manulife Financial
MFC
$72.9B
| $216K | ﹤0.01% |
5,962
+1,687
| +39% | +$57.3K |
|
2891
Aclaris Therapeutics
ACRS
$863M
| $216K | ﹤0.01% |
71,804
-19,432
| -21% | -$49.1K |
|
2892
Resources Connection
RGP
$145M
| $216K | ﹤0.01% |
42,790
-6,162
| -13% | -$29.4K |
|
2893
Stellantis
STLA
$20.2B
| $216K | ﹤0.01% |
19,802
| – | – |
|
2894
Health Catalyst
HCAT
$132M
| $215K | ﹤0.01% |
90,055
-6,801
| -7% | -$18.6K |
|
2895
BV Financial
BVFL
$180M
| $215K | ﹤0.01% |
11,861
-1,442
| -11% | -$24.8K |
|
2896
MaxCyte
MXCT
$149M
| $214K | ﹤0.01% |
138,133
-10,484
| -7% | -$16.7K |
|
|
STRZ
2897
Starz Entertainment Corp
STRZ
$479M
| $214K | ﹤0.01% |
18,273
-1,243
| -6% | -$14.2K |
|
2898
DiaMedica Therapeutics
DMAC
$364M
| $213K | ﹤0.01% |
26,761
-596
| -2% | -$4.46K |
|
2899
Quantum-Si Incorporated
QSI
$172M
| $213K | ﹤0.01% |
193,595
-26,370
| -12% | -$42.9K |
|
2900
Perspective Therapeutics
CATX
$354M
| $211K | ﹤0.01% |
76,571
-8,234
| -10% | -$23.5K |
|
Similar funds
RhumbLine Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
- RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
- RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
- RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
- RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
- RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
- RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.
Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.